161 related articles for article (PubMed ID: 36864537)
1. A protein-based subunit vaccine with biological adjuvants provides effective protection against Pasteurella multocida in pigs.
Wu MC; Wu HC; Lee JW; Chang WC; Chu CY
Vet Res; 2023 Mar; 54(1):17. PubMed ID: 36864537
[TBL] [Abstract][Full Text] [Related]
2. Recombinant suilysin of Streptococcus suis enhances the protective efficacy of an engineered Pasteurella multocida toxin protein.
Wu MC; Doan TD; Lee JW; Lo YT; Wu HC; Chu CY
Res Vet Sci; 2022 Dec; 151():175-183. PubMed ID: 36041311
[TBL] [Abstract][Full Text] [Related]
3. Cross-protection of recombinant Pasteurella multocida toxin proteins against atrophic rhinitis in mice.
Wu MC; Lo YT; Wu HC; Wang HY; Chu CY
Res Vet Sci; 2021 Jul; 137():138-143. PubMed ID: 33975192
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity and efficacy of three recombinant subunit Pasteurella multocida toxin vaccines against progressive atrophic rhinitis in pigs.
Liao CM; Huang C; Hsuan SL; Chen ZW; Lee WC; Liu CI; Winton JR; Chien MS
Vaccine; 2006 Jan; 24(1):27-35. PubMed ID: 16122849
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity and protective efficacy of a multi-epitope recombinant toxin antigen of Pasteurella multocida against virulent challenge in mice.
Liang W; Xiao H; Chen JY; Chang YF; Cao SJ; Wen YP; Wu R; Du SY; Yan QG; Huang XB; Zhao Q
Vaccine; 2023 Mar; 41(14):2387-2396. PubMed ID: 36872144
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of a novel Pasteurella multocida vaccine against progressive atrophic rhinitis of swine.
Hsuan SL; Liao CM; Huang C; Winton JR; Chen ZW; Lee WC; Liao JW; Chen TH; Chiou CJ; Yeh KS; Chien MS
Vaccine; 2009 May; 27(22):2923-9. PubMed ID: 19428902
[TBL] [Abstract][Full Text] [Related]
7. Vaccination against progressive atrophic rhinitis with a recombinant Pasteurella multocida toxin derivative.
Nielsen JP; Foged NT; Sørensen V; Barfod K; Bording A; Petersen SK
Can J Vet Res; 1991 Apr; 55(2):128-38. PubMed ID: 1832079
[TBL] [Abstract][Full Text] [Related]
8. Immunization of rabbits against Pasteurella multocida using a commercial swine vaccine.
Suckow MA
Lab Anim; 2000 Oct; 34(4):403-8. PubMed ID: 11072861
[TBL] [Abstract][Full Text] [Related]
9. Expression of a truncated Pasteurella multocida toxin antigen in Bordetella bronchiseptica.
Rajeev S; Nair RV; Kania SA; Bemis DA
Vet Microbiol; 2003 Jul; 94(4):313-23. PubMed ID: 12829385
[TBL] [Abstract][Full Text] [Related]
10. Development of a genetically modified nontoxigenic Pasteurella multocida toxin as a candidate for use in vaccines against progressive atrophic rhinitis in pigs.
To H; Someno S; Nagai S
Am J Vet Res; 2005 Jan; 66(1):113-8. PubMed ID: 15691045
[TBL] [Abstract][Full Text] [Related]
11. Expression of 4 truncated fragments of Pasteurella multocida toxin and their immunogenicity.
Seo J; Pyo H; Lee S; Lee J; Kim T
Can J Vet Res; 2009 Jul; 73(3):184-9. PubMed ID: 19794890
[TBL] [Abstract][Full Text] [Related]
12. Effect of Bordetella bronchiseptica and serotype D Pasteurella multocida bacterin-toxoid on the occurrence of atrophic rhinitis after experimental infection with B. bronchiseptica and toxigenic type AP. multocida.
Sakano T; Okada M; Taneda A; Mukai T; Sato S
J Vet Med Sci; 1997 Jan; 59(1):55-7. PubMed ID: 9035080
[TBL] [Abstract][Full Text] [Related]
13. Vaccine efficacy for reducing turbinate atrophy and improving growth rate in piggeries with endemic atrophic rhinitis.
Kabay MJ; Mercy AR; Lloyd JM; Robertson GM
Aust Vet J; 1992 May; 69(5):101-3. PubMed ID: 1627085
[TBL] [Abstract][Full Text] [Related]
14. Atrophic rhinitis vaccine composition triggers different serological profiles that do not correlate with protection.
Magyar T; Donkó T; Kovács F
Acta Vet Hung; 2008 Mar; 56(1):27-40. PubMed ID: 18401954
[TBL] [Abstract][Full Text] [Related]
15. Recombinant-attenuated Salmonella enterica serovar Choleraesuis vector expressing the PlpE protein of Pasteurella multocida protects mice from lethal challenge.
Zhou G; Tian J; Tian Y; Ma Q; Li Q; Wang S; Shi H
BMC Vet Res; 2023 Aug; 19(1):128. PubMed ID: 37598169
[TBL] [Abstract][Full Text] [Related]
16. Antigenicity of partial fragments of recombinant Pasteurella multocida toxin.
Lee J; Woo HJ
J Microbiol Biotechnol; 2010 Dec; 20(12):1756-63. PubMed ID: 21193834
[TBL] [Abstract][Full Text] [Related]
17. Virulence of Pasteurella multocida in atrophic rhinitis of gnotobiotic pigs infected with Bordetella bronchiseptica.
Rutter JM
Res Vet Sci; 1983 May; 34(3):287-95. PubMed ID: 6878879
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity and protective efficacy of the recombinant
Li Y; Xiao J; Chang YF; Zhang H; Teng Y; Lin W; Li H; Chen W; Zhang X; Xie Q
Front Immunol; 2022; 13():985993. PubMed ID: 36275745
[TBL] [Abstract][Full Text] [Related]
19. Pasteurella multocida inactivated with ferric chloride and adjuvanted with bacterial DNA is a potent and efficacious vaccine in Balb/c mice.
Homayoon M; Tahamtan Y; Kargar M; Hosseini SMH; Akhavan Sepahy A
J Med Microbiol; 2018 Sep; 67(9):1383-1390. PubMed ID: 30016232
[TBL] [Abstract][Full Text] [Related]
20. Vaccine potential of an attenuated Pasteurella multocida that expresses only the N-terminal truncated fragment of P. multocida toxin in pigs.
Kim T; Son C; Lee J; Kim K
Can J Vet Res; 2012 Jan; 76(1):69-71. PubMed ID: 22754098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
